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INTRODUCTION 
 
There are two mosquito-borne diseases of concern in Massachusetts, Eastern equine encephalitis 
(EEE), which was identified as a human disease in 1938, and West Nile virus (WNV) infection, 
which has been present in the United States since 1999. EEE is a rare but serious neuroinvasive 
disease that causes meningitis or encephalitis, and often results in death or severe disability. 
WNV infection is more common, though typically less severe than EEE; presentation of WNV 
ranges from febrile illness to neuroinvasive disease. Although 51 different species of mosquitoes 
have been identified in Massachusetts, only a few of these contribute to either WNV or EEE 
spread. For more information, visit the MDPH website to view Common Mosquitoes That Can 
Spread Disease in Massachusetts. 
 
Currently there are no available vaccines to prevent human infections from either mosquito-
borne virus. Personal protection measures that serve to reduce exposure to mosquitoes and 
thereby prevent human infection remain the mainstay of prevention. To estimate the risk of 
human disease during a mosquito season, the MDPH, in cooperation with the local Mosquito 
Control Projects, conducts surveillance for EEE and WNV using mosquito samples, and 
specimens from human and veterinary sources. Detailed information about surveillance for these 
diseases in Massachusetts is available on the MDPH website at Arbovirus Surveillance and 
Control Plan. 
 
EASTERN EQUINE ENCEPHALITIS VIRUS 
 
Humans 
There have been no human cases of EEE virus infection identified in Massachusetts since 2013. 
 
Mosquito Samples 
Of 5,496 mosquito samples collected in Massachusetts in 2017, one sample (0.02%) was positive 
for EEE virus in 2017. The positive samples were identified in the town of Westport. For a 
complete list of positive mosquito samples by city/town, please see the 2017 Mosquito Summary 
by County and Municipality report posted on the MDPH website. 
 
Animals  
Four veterinary samples were submitted for arbovirus testing.  There were no animals that tested 
positive for EEE virus infection in 2017. 
 
 Birds 
Although birds are not routinely tested as part of EEE surveillance, species such as emus or 
exotic quail may experience sudden illness and mortality due to EEE. Farmed birds showing 
these signs must be reported promptly to the Massachusetts Department of Agricultural 
Resources (MDAR). No reports were received in 2017. 
 
EEE Geographic Risk Levels 
EEE risk maps combine historical data and areas of mosquito habitat with current data on 
positive virus isolations (in humans, mosquitoes, etc.) and weather conditions. Risk levels are an 
estimate of the likelihood of an outbreak of human disease and are updated weekly based on 
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surveillance data.  Initial and final EEE risk levels from the 2017 season are shown in the 
following maps. This information will be used to help anticipate risk in 2018, and will be revised 
as 2018 surveillance data are collected. More detailed information about risk assessment and risk 
levels is available in the Arbovirus Surveillance and Response Plan on the MDPH web site. 
 
 
Initial and Final 2017 EEE Risk Categories 
 
 (As defined in Table 2 of the MDPH Arbovirus Surveillance and Response Plan which can be 
found at www.mass.gov/dph/mosquito under “Surveillance Summaries and Data”) 
 
 
 
 
 
 
2017 EEE SEASON DISCUSSION 
There were no confirmed human EEE cases in 2017 or 2016, compared to seven confirmed 
human cases in 2012 and one in 2013; 2012 was the most recent outbreak year in Massachusetts. 
The number of confirmed human cases nationwide was lower in 2017 (three) and 2016 (seven) 
when compared to 2012 (15).   
 
There was a similar decline in EEE virus positive mosquito samples from 267 in 2012 to one in 
2017. In 2017, MDPH identified one EEE positive sample of Culiseta melanura, the enzootic 
vector of EEE. Mosquito surveillance activities are highly adaptive to identifications of EEE 
virus, with more mosquito trapping and testing in years when EEE activity is increased, this 
makes year-to-year comparisons somewhat difficult. In general, years with increased EEE 
human infections are associated with an increase in the percentage of Cs. melanura samples 
positive for EEE virus (see figure below).  
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Why has there been less EEE activity since 2012?  
Historically, EEE outbreaks have rarely occurred during periods lasting more than three years, 
although evidence suggests that previously observed patterns may be changing and the situation 
must be monitored carefully. Intense EEE activity consistent with outbreaks occurred in 2004-
2006 and 2010-2012. Outbreaks are probably supported, in part, by previously unexposed 
populations of birds that are susceptible to EEE virus infection, and therefore capable of 
maintaining the cycle of virus transmission. Current research also suggests that each of these 
cycles is associated with the introduction of a new strain of EEE virus by migratory birds. After 
three years (2010-2012) of intense virus activity, the population of susceptible birds may not 
have been adequate to maintain the virus cycle in more recent years. Important factors also 
impacting EEE virus cycles include large Cs. melanura mosquito populations which are more 
likely to support significant EEE activity, and weather conditions, such as significant 
precipitation events and prolonged periods of high temperature. In 2012, significant precipitation 
and prolonged periods of high temperatures provided favorable conditions for mosquito 
development. In 2016, below average precipitation in winter, spring, and summer combined with 
above-average summer temperatures reduced available breeding habitat for the traditional 
vectors of EEE and led to below-average mosquito abundance rates throughout the breeding 
season. In 2017, the mosquito season began with average precipitation events. Precipitation 
events declined sharply in early summer and then rebounded to average precipitation and 
temperature for the remainder of the 2017 mosquito season. While breeding area for Cs. 
melanura was increased compared to prior years, abundance levels of Cs. melanura remained 
low due to the impact of drought conditions seen in 2016.   
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Variability in Geographic Range of EEE 
In Massachusetts over the last ten years, some human EEE cases have occurred outside of the 
historic area of risk and there have been year-to-year variations in the geographic pattern of 
disease occurrence. This is not unique to Massachusetts; during 2013-2016, human cases of EEE 
were reported from neighboring states including Connecticut, Maine, New Hampshire, New 
York, Rhode Island, and Vermont. Many of these cases were unusual in that they occurred in: 
states which rarely see EEE cases (Connecticut and Rhode Island); states where EEE cases are a 
very recent occurrence (Maine, New Hampshire and Vermont); and in atypical areas in states 
that have historic areas of risk (New York). MDPH continues to perform adaptive surveillance 
activities to provide for early detection of EEE throughout the Commonwealth.    
 
                                   
What are the expectations for EEE in 2018? 
Mosquito abundance and vector-borne disease risk are affected by multiple environmental 
factors which vary over time and geographic location. The two most important contributors to 
mosquito development are precipitation and temperature. All species of mosquito depend on the 
presence of water for the first stages of life. Mosquito populations increase when precipitation is 
plentiful and decrease during dry periods. Warmer temperatures shorten both the time it takes for 
mosquitoes to develop from egg to adult and the time it takes for a mosquito to be able to 
transmit a pathogen after ingesting an infected blood meal. 
 
Warm and wet winters increase the likelihood of mosquito survival and may lead to higher 
spring mosquito numbers. The summer and fall of 2017 brought average temperatures and 
precipitation events leading to sufficient breeding habitat for the traditional vectors of EEE. A 
preliminary assessment of the winter of 2017-2018 has demonstrated periods of colder than 
average temperatures combined with average precipitation events. Early reports from the field 
indicate below average numbers of juvenile Cs. melanura. 
 
Mosquito populations alone are not sufficient to produce significant EEE risk; infected bird 
populations are also necessary.  Unfortunately, less is known about the factors that lead to large 
numbers of infected birds, making this component of risk impossible to predict. At this time 
there is no efficient method to conduct surveillance for infection levels in wild birds.  
 
In Massachusetts, human EEE 
infection is associated with 
Culiseta melanura activity. The 
map to the right illustrates that 
one area at highest risk for 
transmission of EEE is 
Southeastern Massachusetts 
which has also been the historic 
area of risk. Northeastern 
Massachusetts has become an 
area of high risk more recently. 
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Both the variability of New England weather and the inability to detect EEE virus infection 
levels in wild bird populations require that Massachusetts maintain a robust surveillance system 
every year to detect EEE virus in mosquitoes as a tool to assess risk of human disease. 
 
WEST NILE VIRUS  
 
Humans 
There were six human cases of WNV infection identified in Massachusetts in 2017. The results 
are summarized in the table below. 
 
County Age Range Onset Date Virus Result  Clinical Presentation 
Bristol  51-60 8/15/2017 WNV ENCEPHALITIS   
Hampden  61-70 9/10/2017 WNV ENCEPHALITIS   
Middlesex  61-70 10/1/2017 WNV MENINGOENCEPHALITIS 
Barnstable  71-80 10/15/2017 WNV MENINGITIS 
Middlesex  71-80 10/3/2017 WNV ENCEPHALITIS   
Middlesex  31-40 10/19/2017 WNV FEVER 
 
Presumptive Viremic Blood Donors 
WNV is transmissible through blood transfusion. Since June 2003, blood banks have screened 
donated blood for WNV using a nucleic acid test (NAT) that identifies viral genetic material. 
Positive units are not used and donors are deferred from future donation for 120 days.  The 
AABB (formerly the American Association of Blood Banks) notifies states of all presumptive 
viremic donors (PVDs), i.e., individuals whose donated blood tests positive using the NAT test. 
 
There was one PVD identified in Massachusetts in 2017. The number of PVDs nationwide was 
down in 2017 (247) from 2016 (275). 
 
 
 
 
 
 
 
Mosquito Samples 
Of 5,496 mosquito samples collected in Massachusetts in 2017, 290 (5.3%) were positive for 
WNV. Positive mosquito samples included 277 (96%) Culex species.  Positive samples were 
identified in 89 towns in 12 counties. For a complete list of positive mosquito samples by 
city/town, please see the 2017 Mosquito Summary by County and Municipality report posted on 
the MDPH website. 
 
 
Animals 
Four veterinary samples were submitted for arbovirus testing. There were no animals that tested 
positive for WNV in 2017. 
 
 
 
County Donation Date Virus Result  
Norfolk 10/07/2017 WNV 
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WNV Geographic Risk Levels 
WNV risk maps are produced by integrating historical data and areas of mosquito habitat with 
current data on positive virus identifications (in humans, mosquitoes, etc.) and weather 
conditions. Risk levels serve as a relative measure of the likelihood of an outbreak of human 
disease and are updated weekly based on that week’s surveillance data. Initial and final WNV 
risk levels from the 2017 season are provided in the following maps. This information will be 
used to help predict risk in 2018, and will be revised as 2018 surveillance data are collected. 
More detailed information about risk assessment and risk levels is available in the Arbovirus 
Surveillance and Response Plan on the MDPH web site during the arbovirus season. 
 
Initial and Final 2017 WNV Risk Categories 
 (As described in Table 1 of the MDPH Arbovirus Surveillance and Response Plan which can be 
found at www.mass.gov/dph/mosquito under “Surveillance Summaries and Data”) 
 
                                                                    
2017 WNV SEASON DISCUSSION 
MDPH identified six confirmed human WNV infections in 2017 compared to 16 confirmed 
cases in 2016.  The number of confirmed human cases nationwide in 2017 (2,002) was slightly 
less than in 2016 (2,038) but far fewer than the 2012 outbreak (5,674).    
   
Of the 2,002 cases identified nationally in 2017, 1,339 (67%) were classified as neuroinvasive 
disease (defined as meningitis or encephalitis) and 663 (33%) were classified as non-
neuroinvasive disease.  The majority of the cases were reported from four states (California, 
Texas, Arizona and Illinois). 25% of all cases were reported from California.  
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WNV Positive Mosquitoes and Correlation with Human Disease 
In 2017, MDPH identified 277 WNV positive Culex species mosquito samples as compared to 
185 WNV positive Culex species mosquito samples in 2016. In general, years with increased 
WNV human infections are associated with an increase in the percentage of Culex samples 
positive for WNV (see figure below). Considering the increase in human cases of WNV 
infection that occurred from 2014-2016, an increase in WNV positive mosquito samples might 
be expected. As the graph below demonstrates, the percentage of WNV positive Culex mosquito 
samples decreased sharply from a peak in 2012, associated with a notably hot summer resulting 
in a national outbreak, to a low in 2014 with an uptick in 2015 and 2016. In 2017 the difference 
in confirmed human cases compared to WNV positive mosquito samples is likely due to an 
increase in Culex mosquito testing from areas with high levels of West Nile virus activity.  
 
 
 
In Massachusetts, the vectors for WNV are 
primarily Culex species. Culex species are 
closely associated with human activity. The 
map to the right illustrates that transmission 
to humans is generally highest in counties 
with higher population densities. 
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What are the expectations for WNV in 2018? 
The primary determinants of human WNV disease risk during any particular season are 
populations of Culex mosquito species and the presence of infected birds. The two most 
important variables for mosquito development are precipitation and temperature. Warmer 
temperatures shorten both the time it takes for mosquitoes to develop from egg to adult and the 
time it takes for a mosquito to be able to transmit a pathogen after ingesting an infected blood 
meal. Culex mosquito populations tend to be greatest during seasons with periodic precipitation 
events (giving rise to stagnant puddles that favor Culex breeding).separated by hot, dry days  
 
Mosquito populations alone are not sufficient to produce significant WNV risk; infected bird 
populations are also necessary.  Unfortunately, less is known about the factors that lead to large 
numbers of infected birds making this component of risk impossible to predict and there is no 
efficient way to conduct surveillance for infection levels in wild birds.  
 
The lack of useful pre-season predictive factors limits the ability of MDPH to make any accurate 
assessments regarding future WNV activity. Both the variability of New England weather, and 
the inability to detect WNV infection levels in wild bird populations, requires that Massachusetts 
maintain a robust surveillance system to detect WNV in mosquitoes as a primary tool to assess 
risk of human disease. MDPH continues to strive to identify reliable measures to aid in risk 
assessments.   
 
Invasive Mosquito Species Surveillance 
 
MDPH and its partners are taking proactive measures to conduct surveillance for invasive 
mosquito species that are expanding their geographic range northward, especially for 
Aedes albopictus. Ae. albopictus is an aggressive mammal-biting species that was introduced to 
North America from Asia around 1985. This species has been implicated in the transmission 
of arboviruses such as dengue, chikungunya, yellow fever, and Zika, in some parts of the world. 
Where it occurs, this species is generally more abundant in urban areas, breeding in artificial 
containers, such as birdbaths, discarded tires, buckets, clogged gutters, catch basins, and other 
standing water sources. These mosquitoes are aggressive biters that actively seek out mammals, 
including humans, during daytime hours. 
 
          
Zika Virus Surveillance 
Limited detections of Ae. albopictus 
were first identified in Southeastern 
MA in 2009. Since these initial 
detections, additional findings have 
been recorded outside Southeastern 
MA. With the use of ovitraps Ae. 
albopictus has now been detected in 15 
communities throughout the state since 
2009. MDPH will continue to conduct 
routine surveillance activities to 
monitor for the presence and 
expansion of Ae. albopictus and other 
invasive mosquito species.          
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The global Zika virus outbreak began in South America in December 2015. Throughout 2016 – 
2017 Zika virus spread across much of the globe. Zika virus is transmitted by Aedes mosquitoes. 
Symptoms appear in only 20% of cases, the majority of patients experience no symptoms. Those 
individuals that do experience symptoms typically have low-grade fever, muscle and or joint 
pain, rash, conjunctivitis, nausea, and diarrhea. The disease resolves with supportive treatment. 
However, in pregnant women who become infected with Zika virus, it is possible for the virus to 
spread to the developing fetus. When this happens, it can result in birth defects, including 
abnormal brain and head development (microcephaly). 
 
In 2017, the Massachusetts State Public Health Laboratory tested 3,013 residents for Zika virus; 
77 (2.6%) were positive. All cases were investigated and determined to be travel associated. 
There have been no cases of Zika virus acquired locally from mosquitoes in Massachusetts. 
Since Zika virus is not a locally transmitted mosquito-borne disease, there are no plans to test 
mosquitoes in Massachusetts for Zika virus.  
   
 
